Don’t Let PainPut Your Life On Hold
Recognized as a global leader in hyaluronic acid technology, and for always pioneering what’s next, Fidia offers patients much more than pain relief solutions – we offer hope to live better.
Recent Company News
- April 22, 2020COVID-19: to all Fidia Partners, Customers and SuppliersThe health, well-being and safety of the people we engage with, including you, our customers, partners, and suppliers, as well as all of our employees, continues to be a top priority for Fidia.Read More
- March 12, 2020COVID-19: communication to Partners, Customers, SuppliersFidia has implemented a series of measures, to minimize any potential risks related with the COVID-19 outbreak, guaranteeing full operations in, from and to the factories, as well as transports of goods and supply of materials.Read More
- December 2, 2019Fidia Introduces in the US the 3-injection regimen TRILURON™ (sodium hyaluronate)Florham Park, N.J., December 2, 2019 – Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronic acid-based products and its wholly owned subsidiary, Fidia Pharma USA Inc., introduce in the US, TRILURON™ (sodium hyaluronate).Read More